Drug Database
HY

hydroquinone (Tanit)

✓ Approved

Vinas · Small Molecule · Small Molecule

What is hydroquinone?

hydroquinone is a small molecule developed by Vinas. It is approved for therapeutic indications.

Drug Profile

Brand NamesTanit
CompanyVinas
Drug ClassSmall Molecule
StatusApproved

Therapeutic Indications

hydroquinone is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Skin and subcutaneous tissue disordersSkin hyperpigmentation✓ Approved

Related Research Articles

PubMedChemPlusChem2026-08-31

Synergistic Role of Co0 and Lewis Basic Sites for Transfer Hydrogenation of Substituted Nitroarenes by In Situ Hydrogen Generation.

Sharma Anitya A, Ramchiary Dhanmani D, Sharma Devendra D, Kumar Sahil S et al.

Designing green and efficient methods for synthesizing anilines remains a key challenge in synthetic organic chemistry. Hydrogenation of nitro compounds is one of the most significant and widely employed method for producing functionalized anilines. Consequently, designing catalytic systems capable of hydrogenating nitroarenes under environmentally benign and mild reaction conditions remains a challenge. In this regard, a highly efficient CoAl catalyst has been designed for the hydrogenation of nitroarenes to corresponding amines. Various structural, compositional, and morphological characterizations were done to understand the catalyst's structural and surface properties. The as-synthesized catalyst exhibits excellent activity for the transfer hydrogenation of 1-chloro-4-nitrobenzene to 4-chloroaniline, achieving 98% yield at 60 °C within 1.5 h in ethanol. The developed protocol demonstrated excellent activity for wide range of substituted nitroarenes. Structure-activity relationships of CoAl show that basic sites play a crucial role in the transfer hydrogenation. Furthermore, mechanistic investigations reveal that transfer hydrogenation occurs predominantly via a hydroxylamine-mediated pathway. Moreover, the catalyst maintains good catalytic activity up to four consecutive cycles. This method eliminates the need for high-pressure H2, offering a safe strategy for aromatic amine synthesis. The work demonstrates the potential of earth-abundant, non-noble-metal-based heterogeneous catalysts for hydrogenation reactions under environmentally benign conditions.

PubMedEuropean radiology2026-08-30

Automated artificial intelligence performance for longitudinal pulmonary nodule matching in lung cancer screening.

Jiang Beibei B, Lancaster Harriet L HL, Davies Michael P A MPA, Gratama Jan-Willem C JC et al.

Accurate longitudinal nodule matching is a critical technical prerequisite for automated growth rate (volume doubling time) assessment in lung cancer screening. This study evaluated an artificial intelligence (AI) pulmonary nodule analysis system in all 361 UK Lung Cancer Screening (UKLS) trial participants who underwent a 3-month follow-up low-dose computed tomography (LDCT) scan. The pulmonary AI independently evaluated these baseline scans using an updated volume threshold (solid component ≥ 100 mm³ per NELSON 2.0/EUPS protocol) for cases requiring 3-month follow-up. To assess true algorithmic robustness, all AI-detected baseline candidate nodules (≥ 100 mm³) proceeded to fully automated longitudinal matching without any manual selection. The pulmonary AI identified 181 participants with 378 baseline nodules ≥ 100 mm³. In total, 39 nodules had naturally resolved at follow-up. The pulmonary AI achieved an 83.5% (283/339; 95% CI: 79.2-87.1%) matching success rate for 339 persisting nodules. Matching performance was 91.8% (89/97) for participants with a single baseline candidate nodule (59.7% of the cohort) and 72.8% (75/103) for participants with more than five nodules (6.6%). Expert review of the 56/339 (16.5%) unmatched findings showed that almost all were non-nodular structures (91.1%, 51/56), predominantly pleural plaques (46.4%, 26/56). Consequently, only five unmatched discrete solid nodules (1.5%; 95% CI: 0.6-3.5% of 339 persisting findings) required manual intervention. In conclusion, the pulmonary AI demonstrates robust longitudinal matching performance, with substantial potential for follow-up manual tracking workload reduction. KEY POINTS: Question Does standalone AI longitudinal nodule tracking provide sufficient nodule-level technical reliability to avoid manual review bottlenecks in an automated lung cancer screening workflow? Findings Pulmonary AI matched 83.5% of persisting nodules (91.8% for single nodules, 72.8% for > 5 nodules); 91.1% failures were non-nodular, with only 1.5% requiring manual correction. Clinical relevance Pulmonary AI matching can potentially reduce the manual tracking workload in lung cancer screening, with only 1.5% of persisting nodules requiring manual correction. Performance is reduced in scans with high nodule burden, and prospective validation in diverse populations is needed.

PubMedOsteoarthritis and cartilage open2026-08-30

Utilization of medications for neuropathic pain in patients with and without knee and hip osteoarthritis in Sweden: A population-based cohort study.

Hellberg Clara C, Turkiewicz Aleksandra A, Sundquist Kristina K, Dell'Isola Andrea A et al.

Use of neuropathic pain medications is increasing in OA patients, but it is unclear if this is driven by OA-specific use or presence of comorbidities. We aimed to investigate the use of neuropathic pain medications attributable to knee and hip OA pain. We included all residents aged ≥35 years of the Skåne region, Sweden, in 2018. After exclusions, 645,991 individuals remained, where 81,606 had diagnosed knee and/or hip OA. We compared prevalence of dispensed neuropathic pain medications between those with and without OA using logistic regression (odds ratios approximated risk ratios [RR]), adjusting for comorbidities associated with use of such medications. We interpreted any higher prevalence remaining after adjustment as being compatible with possible OA-related use. Due to interaction effect, males and females were studied separately. Among OA females, crude prevalence of dispensed neuropathic pain medications was highest among 45-54-year-olds (4.0%), with a decreasing prevalence toward 75-84-year-olds (2.3%) compared to 1.5% in non-OA females. After adjusting for comorbidities, the RR for females with vs without OA was 1.4 (95% CI 1.3-1.6) at age 50 and 1.0 (95% CI 0.9-1.1) at age 80. Males had similar prevalence of use across ages, 1.5% in persons with OA and 0.8% in persons without. After adjustment for comorbidities there was no association between OA and neuropathic medication dispensations (RR 1.0; 95% CI 0.9-1.1). In particular, middle-aged OA females may use neuropathic pain medications for treatment of OA-related pain, as increased prescribing remained after adjusting for relevant comorbidities.

PubMedJHLT open2026-08-30

Routine care practices for stable lung allograft recipients beyond the initial post-transplant year: An international survey study.

Toporek Alexandra H AH, Gannon Whitney D WD, Croglio Michael P MP, Motta-Calderon Daniel D et al.

The pragmatic aspects of routine lung transplant recipient management are poorly described. We performed an international survey study to characterize management of stable lung transplant recipients who are beyond the initial post-transplant year. We obtained survey responses from 72 distinct lung transplant programs in 15 countries. Stable patients are monitored a median of every 3-months (IQR 3-3.25) in the ambulatory setting. Visits are accompanied by diagnostic laboratory assessments, spirometry, and chest X-ray imaging. Most centers perform between-clinic surveillance every 1-month (IQR 1-1.5) with diagnostic laboratory testing. We identified the frequency of monitoring of donor-specific antibodies [median 6 months (IQR 3-6)], chest computed tomography [median 12 months (IQR 12-12)], and other ancillary testing. A majority of stable patients are managed on a maintenance immunosuppression regimen of tacrolimus (preferred goal trough 8-10 ng/ml), mycophenolate, and prednisone (preferred dose of 5 mg daily). Dose reduction of immunosuppression occurs for cytopenias, recurrent infection, malignancy, and short telomere syndromes at most centers. Methodologies and frequencies for malignancy screening are described. While routine care of lung transplant recipients is heterogeneous, there are potential areas of consensus in practice patterns.

PubMedACS applied materials & interfaces2026-08-30

Degradation Mechanisms of Fluorinated Disordered Rocksalt Cathodes: Effects of Electrolyte Chemistry and Discharge Voltage.

Ahmed Ridwan A RA, Lee Gi-Hyeok GH, Hershkovitz Eitan E, Li Tianyu T et al.

Cation-disordered rock-salt (DRX) oxides have emerged as a promising class of high energy density cathodes for next-generation lithium-ion batteries. Fluorination has been widely employed to tune the redox chemistry and structural stability of these materials, leading to enhanced electrochemical performance. However, the degradation mechanisms of fluorinated DRX (F-DRX) cathodes during electrochemical cycling remain poorly understood. Here, we investigate the degradation behavior of an F-DRX cathode cycled in a conventional carbonate-based electrolyte and a localized high-concentration electrolyte (LHCE). By correlating electrochemical performance with interfacial and bulk structural evolution, we elucidate the role of electrolyte chemistry and deep discharge voltage in governing structural transformation and degradation. The results reveal more pronounced surface and bulk structural changes in the conventional LiPF6-carbonate electrolyte relative to LiFSI-LHCE, indicating accelerated degradation in the former. Lowering the discharge cutoff voltage from 2.0 to 1.5 V further promotes interfacial degradation in both electrolyte systems. This work demonstrates that the LHCE offers superior compatibility with F-DRX cathodes, enabling stable cycling by mitigating surface and bulk structural degradation. These insights clarify the interplay between electrolyte chemistry and voltage window in F-DRX degradation and highlight the critical importance of advanced electrolyte designs for unlocking the full potential of DRX cathodes.

PubMedJournal of chromatography. A2026-08-30

Automated miniaturized LLE-GC-MS/MS for the analysis of EPA 8270 SVOCs and multi-class pesticides in water using ethyl acetate.

Feo Maria Luisa ML, Benedetti Paolo P, Zanaboni Moira M, Tofful Luca L et al.

The determination of trace-level semi-volatile organic compounds (SVOCs) following EPA Method 8270 traditionally relies on manual liquid-liquid extraction (LLE) using large volumes of dichloromethane (DCM). However, recent 2024 TSCA regulations restricting DCM due to human health risks necessitate sustainable analytical alternatives. This study presents a fully automated, miniaturized LLE (micro-LLE) method for 170 analytes including EPA 8270 targets and multi-class pesticides (organochlorine (OCPs), organophosphorus (OPPs) and organonitrogen (ONPs) pesticides and pyrethroids). The workflow utilizes a TriPlus RSH SMART autosampler to integrate standard preparation, surrogate spiking, and extraction with on-line GC-MS/MS injection. Ethyl acetate was validated as a "green" alternative to DCM, with a 1:1 NaCl:MgSO₄ salt mixture optimizing the salting-out effect. This procedure achieved a tenfold enrichment factor using only 1.5 mL of solvent for 10 mL of sample. Method validation showed excellent linearity (R2> 0.995 for 70% of analytes) and precision (RSD < 15%). Method limits of quantification (MLOQs) between 0.05 and 10 µg/L meet stringent regulatory requirements. The method's robustness was confirmed through real-world Saharan deposition samples, identifying high levels of Phenothrin (211 ppb) and Endosulfan ether (140 ppb). This robotic workflow provides a high-throughput, sustainable solution for modern environmental monitoring.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about hydroquinone